WO2025228324 - METHOD FOR TREATING TUMORS WITH ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE
National phase entry is expected:
Publication Number
WO/2025/228324
Publication Date
06.11.2025
International Application No.
PCT/CN2025/091722
International Filing Date
28.04.2025
Title **
[English]
METHOD FOR TREATING TUMORS WITH ANTI-NECTIN-4 ANTIBODY-DRUG CONJUGATE
[French]
MÉTHODE DE TRAITEMENT DE TUMEURS AVEC UN CONJUGUÉ ANTICORPS ANTI-NECTINE-4-MÉDICAMENT
[Chinese]
抗Nectin-4抗体药物偶联物治疗肿瘤的方法
Applicants **
BIO-THERA SOLUTIONS, LTD.
Inventors
ZHOU, Xiaoyan
FU, Ziyi
MEI, Xingxing
TANG, Weijia
SONG, Shuqiang
YU, Jin-Chen
LI, Shengfeng
Priority Data
202410527663.2
28.04.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2271 | |
| EPO | Filing, Examination, Granting | 18908 | |
| Japan | Filing, Examination, Granting | 2553 | |
| South Korea | Filing, Examination, Granting | 3001 | |
| USA | Filing, Examination, Granting | 6340 |
Total:
33,073
Contact Us
Abstract[English]
A method for treating tumors with an anti-Nectin-4 antibody-drug conjugate, and the use thereof. The method comprises administering to a patient an effective amount of the anti-Nectin-4 antibody-drug conjugate.[French]
L'invention concerne une méthode de traitement de tumeurs avec un conjugué anticorps anti-nectine-4-médicament et son utilisation. La méthode comprend l'administration à un patient d'une quantité efficace du conjugué anticorps anti-nectine-4-médicament.[Chinese]
抗Nectin-4抗体药物偶联物治疗肿瘤的方法和用途，其包括向患者施用有效量的抗Nectin-4抗体药物偶联物。